L. S. Ebbesen

Most-cited papers

1. Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors

   B. Konkle, L. S. Ebbesen, E. Erhardtsen, R. P. Bianco +3 more

   2007Journal of Thrombosis and Haemostasis349 citations Open access

   Semantic Scholar

   Save

2. Secondary prophylaxis with recombinant activated factor VII improves health‐related quality of life of haemophilia patients with inhibitors

   W. Hoots, L. S. Ebbesen, B. Konkle, G. Auerswald +4 more

   2008Haemophilia104 citations

   Semantic Scholar

   Save

3. Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications

   I. Titlestad, L. S. Ebbesen, A. Ainsworth, S. Lillevang +2 more

   2001International Journal of Colorectal Disease81 citations

   Semantic Scholar

   Save

4. Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial

   G. Young, L. S. Ebbesen, D. Viuff, J. Di Paola +4 more

   2008Blood Coagulation and Fibrinolysis55 citations

   Semantic Scholar

   Save

5. Hyperhomocysteinemia, thrombosis and vascular biology.

   L. S. Ebbesen

   2004Cellular and Molecular Biology20 citations

   Semantic Scholar

   Save

6. Randomized, Prospective Clinical Trial of rFVIIa for Secondary Prophylaxis in Hemophilia Patients with Inhibitors.

   B. Konkle, L. S. Ebbesen, U. Friedrich, R. P. Bianco +3 more

   200615 citations

   Semantic Scholar

   Save

7. Hyperhomocysteinemia due to folate deficiency is thrombogenic in rats.

   L. S. Ebbesen, K. Christiansen, J. Ingerslev

   2003Journal of NutriLife15 citations Open access

   Semantic Scholar

   Save

8. Folate deficiency induced hyperhomocysteinemia changes the expression of thrombosis-related genes

   L. S. Ebbesen, S. Olesen, M. Kruhøffer, J. Ingerslev +1 more

   2006Blood Coagulation and Fibrinolysis12 citations

   Semantic Scholar

   Save

9. Folate Deficiency-Induced Hyperhomocysteinemia Attenuates, and Folic Acid Supplementation Restores, the Functional Activities of Rat Coagulation Factors XII, X, and II 1,2

   L. S. Ebbesen, J. Ingerslev

   20054 citations

   Semantic Scholar

   Save

10. Secondary Prophylaxis with rFVIIa Improves Quality of Life of Hemophilia Patients with Inhibitors and Frequent Bleeds.

    B. Konkle, L. S. Ebbesen, G. Auerswald, U. Friedrich +3 more

    20063 citations

    Semantic Scholar

    Save

11. [Skin-sparing surgical revision in a woman with necrotizing fasciitis in her face].

    Pia Cajsa ten Voorde, Bro Breiting, L. S. Ebbesen

    2015Ugeskrift for læger1 citations

    Semantic Scholar

    Save

12. Burn Patients with TBSA ≤ 30 % Display Whole Blood Hypercoagulablility 14 days ’ Post Trauma

    C. Lang, J. O. Berg, S. Ostrowski, P. Johanson +1 more

    20170 citations

    Semantic Scholar

    Save

13. Hyperhomocysteinemia (HH) down regulates thrombin generation. FII:C, FXII:C and FX:C are down-regulated in HH while FVII:C is unaffected by HH

    L. S. Ebbesen, K. Christiansen, J. Ingerslev

    20030 citations

    Semantic Scholar

    Save

14. Feasibility of LMW Heparin Prophylaxis for Management of Thrombophilia Investigation in Patients on Oral Anticoagulation Therapy

    Benny Sørensen, Gitte L. Nielsen, L. S. Ebbesen, Jørgen Ingerslev

    2001Thrombosis and Haemostasis0 citations

    Semantic Scholar

    Save